Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors.

Koeppel F, Bobard A, Lefebvre C, Pedrero M, Deloger M, Boursin Y, Richon C, Chen-Min-Tao R, Robert G, Meurice G, Rouleau E, Michiels S, Massard C, Scoazec JY, Solary E, Soria JC, André F, Lacroix L.

Cancer J. 2018 Jul/Aug;24(4):153-162. doi: 10.1097/PPO.0000000000000322. Review.

PMID:
30119077
2.

Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.

Koeppel F, Blanchard S, Jovelet C, Genin B, Marcaillou C, Martin E, Rouleau E, Solary E, Soria JC, André F, Lacroix L.

PLoS One. 2017 Nov 21;12(11):e0188174. doi: 10.1371/journal.pone.0188174. eCollection 2017.

3.

Quickly finding a needle in a haystack: a new automated cardiac arrhythmia detection software for preclinical studies.

Koeppel F, Labarre D, Zitoun P.

J Pharmacol Toxicol Methods. 2012 Sep;66(2):92-7. doi: 10.1016/j.vascn.2012.04.008. Epub 2012 Apr 23.

PMID:
22554864
4.

Quantum dot-based sensor for improved detection of apoptotic cells.

Koeppel F, Jaiswal JK, Simon SM.

Nanomedicine (Lond). 2007 Feb;2(1):71-8.

PMID:
17716192
5.

Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.

Serova M, Calvo F, Lokiec F, Koeppel F, Poindessous V, Larsen AK, Laar ES, Waters SJ, Cvitkovic E, Raymond E.

Cancer Chemother Pharmacol. 2006 Apr;57(4):491-9. Epub 2005 Aug 2.

PMID:
16075278
6.

Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.

Koeppel F, Poindessous V, Lazar V, Raymond E, Sarasin A, Larsen AK.

Clin Cancer Res. 2004 Aug 15;10(16):5604-13.

7.

Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.

Poindessous V, Koeppel F, Raymond E, Cvitkovic E, Waters SJ, Larsen AK.

Int J Oncol. 2003 Nov;23(5):1347-55.

PMID:
14532976
8.

Marked activity of irofulven toward human carcinoma cells: comparison with cisplatin and ecteinascidin.

Poindessous V, Koeppel F, Raymond E, Comisso M, Waters SJ, Larsen AK.

Clin Cancer Res. 2003 Jul;9(7):2817-25.

9.

Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes.

Koeppel F, Riou JF, Laoui A, Mailliet P, Arimondo PB, Labit D, Petitgenet O, Hélène C, Mergny JL.

Nucleic Acids Res. 2001 Mar 1;29(5):1087-96.

10.

[Treatment of sound perception deafness with Danaden retard].

Koeppel FW.

MMW Munch Med Wochenschr. 1976 Aug 6;118(32-33):1015-6. German. No abstract available.

PMID:
822295
11.

[Therapy of sound-perception deafness using cinnarizine (Stutgeron forte)].

Koeppel FW.

MMW Munch Med Wochenschr. 1974 Aug 30;116(35):1513-8. German. No abstract available.

PMID:
4214286
12.

[Tebonin treatment of hearing disorders in the elderly].

Koeppel FW.

Munch Med Wochenschr. 1970 Nov 13;112(46):2091-4. German. No abstract available.

PMID:
5537998
13.

[Treatment of diseases of the ear canal and middle ear with Otobacid].

Koeppel FW.

Munch Med Wochenschr. 1970 Apr 24;112(17):806-9. German. No abstract available.

PMID:
5467990
14.

[Therapeutic experiences with massive dose penicillin V-potassium in an otorhinolaryngologic practice].

Koeppel FW.

Dtsch Med J. 1969 Feb 20;20(4):129-32. German. No abstract available.

PMID:
4976058

Supplemental Content

Loading ...
Support Center